JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01119-06v1
80/21/10565    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hargett, D.
Right arrow Articles by Bachenheimer, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hargett, D.
Right arrow Articles by Bachenheimer, S. L.
Journal of Virology, November 2006, p. 10565-10578, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.01119-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Herpes Simplex Virus Type 1 ICP27-Dependent Activation of NF-{kappa}B{triangledown}

Danna Hargett,1,{dagger} Stephen Rice,3 and Steven L. Bachenheimer1,2*

Department of Microbiology and Immunology,1 Lineberger Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7290,2 Department of Microbiology, University of Minnesota Medical School, 420 Delaware Street SE, Mayo Mail Code 196, Minneapolis, Minnesota 554553

Received 31 May 2006/ Accepted 11 August 2006

The ability of herpes simplex virus type 1 (HSV-1) to activate NF-{kappa}B has been well documented. Beginning at 3 to 5 h postinfection, HSV-1 induces a robust and persistent nuclear translocation of an NF-{kappa}B-dependent (p50/p65 heterodimer) DNA binding activity, as measured by electrophoretic mobility shift assay. Activation requires virus binding and entry, as well as de novo infected-cell protein synthesis, and is accompanied by loss of both I{kappa}B{alpha} and I{kappa}Bß. In this study, we identified loss of I{kappa}B{alpha} as a marker of NF-{kappa}B activation, and infection with mutants with individual immediate-early (IE) regulatory proteins deleted indicated that ICP27 was necessary for I{kappa}B{alpha} loss. Analysis of both N-terminal and C-terminal mutants of ICP27 identified the region from amino acids 21 to 63 as being necessary for I{kappa}B{alpha} loss. Additional experiments with mutant viruses with combinations of IE genes deleted revealed that the ICP27-dependent mechanism of NF-{kappa}B activation may be augmented by functional ICP4. We also analyzed two additional markers for NF-{kappa}B activation, phosphorylation of the p65 subunit on Ser276 and Ser536. Phosphorylation of both serines was induced upon HSV infection and required functional ICP4 and ICP27. Pharmacological inhibitor studies revealed that both I{kappa}B{alpha} and Ser276 phosphorylation were dependent on Jun N-terminal protein kinase activity, while Ser536 phosphorylation was not affected during inhibitor treatment. These results demonstrate that there are several layers of regulation of NF-{kappa}B activation during HSV infection, highlighting the important role that NF-{kappa}B may play in infection.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, 837 MEJB, University of North Carolina, Chapel Hill, NC 27599-7290. Phone: (919) 966-2445. Fax: (919) 962-8103. E-mail: bachlab{at}med.unc.edu.

{triangledown} Published ahead of print on 23 August 2006.

{dagger} Present address: Lewis Thomas Lab, Department of Molecular Biology, Princeton University, Washington Rd., Princeton, NJ 08544-1014.


Journal of Virology, November 2006, p. 10565-10578, Vol. 80, No. 21
0022-538X/06/$08.00+0     doi:10.1128/JVI.01119-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.